More to life than death: Molecular determinants of necroptotic and non-necroptotic RIP3 kinase signaling

Current Opinion in Immunology

Volumn 26, Issue 1, 2014, Pages 76-89

  Khan, Nufail ^a,b   Lawlor, Kate E ^a,b   Murphy, James M ^a,b   Vince, James E ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE KINASE; PROTEIN RIP1; PROTEIN RIP3; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; APOPTOSIS; BINDING AFFINITY; CATALYSIS; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; INNATE IMMUNITY; MITOCHONDRIAL PERMEABILITY; MOLECULAR DYNAMICS; NECROPTOSIS; NONHUMAN; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; APOPTOSIS; CASPASE 8; CELL DEATH; DOWN-REGULATION; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; NECROSIS; PROTEIN KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 84888805473     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.10.017     Document Type: Review

References (138)

1. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010, 11:700-714.
2. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975, 72:3666-3670.
3. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998, 188:919-930.
4. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 1998, 187:1477-1485.
5. Holler N., Zaru R., Micheau O., Thome M., Attinger A., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
6. Degterev A., Huang Z., Boyce M., Li Y., Jagtap P., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1:112-119.
7. Degterev A., Hitomi J., Germscheid M., Ch'en I.L., Korkina O., et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 2008, 4:313-321.
8. Zhang D., Lin J., Han J. Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol 2010, 7:243-249.
9. Festjens N., Vanden Berghe T., Cornelis S., Vandenabeele P. RIP1, a kinase on the crossroads of a cell's decision to live or die. Cell Death Differ 2007, 14:400-410.
10. Xie T., Peng W., Liu Y., Yan C., Maki J., et al. Structural basis of RIP1 inhibition by necrostatins. Structure 2013, 21:493-499.
11. Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 2002, 277:9505-9511.
12. Li J., McQuade T., Siemer A.B., Napetschnig J., Moriwaki K., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell 2012, 150:339-350.
13. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004, 5:503-507.
14. Kaiser W.J., Upton J.W., Mocarski E.S. Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol 2008, 181:6427-6434.
15. Stanger B.Z., Leder P., Lee T.H., Kim E., Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 1995, 81:513-523.
16. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996, 4:387-396.
17. Silke J., Meier P. Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation. Cold Spring Harb Perspect Biol 2013, 5:a008730.
18. Vince J.E., Pantaki D., Feltham R., Mace P.D., Cordier S.M., et al. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis. J Biol Chem 2009, 284:35906-35915.
19. Varfolomeev E., Wayson S.M., Dixit V.M., Fairbrother W.J., Vucic D. The inhibitor of apoptosis protein fusion c-IAP2. MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2. J Biol Chem 2006, 281:29022-29029.
20. Varfolomeev E., Goncharov T., Fedorova A.V., Dynek J.N., Zobel K., et al. c-IAP1 and c-IAP2 are critical mediators of TNFalpha-induced NF-kappa B activation. J Biol Chem 2008, 11.
21. Bertrand M.J., Milutinovic S., Dickson K.M., Ho W.C., Boudreault A., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 2008, 30:689-700.
22. Mahoney D.J., Cheung H.H., Mrad R.L., Plenchette S., Simard C., et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A 2008, 105:11778-11783.
23. Haas T.L., Emmerich C.H., Gerlach B., Schmukle A.C., Cordier S.M., et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 2009, 36:831-844.
24. Gerlach B., Cordier S.M., Schmukle A.C., Emmerich C.H., Rieser E., et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011, 471:591-596.
25. Ikeda F., Deribe Y.L., Skanland S.S., Stieglitz B., Grabbe C., et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis. Nature 2011, 471:637-641.
26. Tokunaga F., Nakagawa T., Nakahara M., Saeki Y., Taniguchi M., et al. SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 2011, 471:633-636.
27. Tokunaga F., Iwai K. Involvement of LUBAC-mediated linear polyubiquitination of NEMO in NF-kappaB activation. Tanpakushitsu Kakusan Koso 2009, 54:635-642.
28. Cho Y.S., Challa S., Moquin D., Genga R., Ray T.D., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
29. Wang L., Du F., Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
30. He S., Wang L., Miao L., Wang T., Du F., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009, 137:1100-1111.
31. O'Donnell M.A., Legarda-Addison D., Skountzos P., Yeh W.C., Ting A.T. Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol 2007, 17:418-424.
32. O'Donnell M.A., Hase H., Legarda D., Ting A.T. NEMO inhibits programmed necrosis in an NFkappaB-independent manner by restraining RIP1. PLoS ONE 2012, 7:e41238.
33. Vanlangenakker N., Vanden Berghe T., Bogaert P., Laukens B., Zobel K., et al. cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production. Cell Death Differ 2011, 18:656-665.
34. O'Donnell M.A., Perez-Jimenez E., Oberst A., Ng A., Massoumi R., et al. Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 2011, 13:1437-1442.
35. Hitomi J., Christofferson D.E., Ng A., Yao J., Degterev A., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
36. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., et al. cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 2011, 43:449-463.
37. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., et al. The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 2011, 43:432-448.
38. Geserick P., Hupe M., Moulin M., Wong W.W., Feoktistova M., et al. Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. J Cell Biol 2009, 187:1037-1054.
39. McComb S., Cheung H.H., Korneluk R.G., Wang S., Krishnan L., et al. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death Differ 2012, 19:1791-1801.
40. Moulin M., Anderton H., Voss A.K., Thomas T., Wong W.W., et al. IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 2012, 31:1679-1691.
41. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998, 8:297-303.
42. Degterev A., Maki J.L., Yuan J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ 2013, 20:366.
43. Takahashi N., Duprez L., Grootjans S., Cauwels A., Nerinckx W., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012, 3:e437.
44. Zhang D.W., Shao J., Lin J., Zhang N., Lu B.J., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
45. Newton K., Sun X., Dixit V.M. Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 2004, 24:1464-1469.
46. McQuade T., Cho Y., Chan F.K. Positive and negative phosphorylation regulates RIP1 and RIP3-induced programmed necrosis. Biochem J 2013, [Epub ahead of print]. 10.1042/BJ20130860.
47. Chen W., Zhou Z., Li L., Zhong C.Q., Zheng X., et al. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 2013, 288:16247-16261.
48. Sun L., Wang H., Wang Z., He S., Chen S., et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 2012, 148:213-227.
49. Thapa R.J., Basagoudanavar S.H., Nogusa S., Irrinki K., Mallilankaraman K., et al. NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol Cell Biol 2011, 31:2934-2946.
50. Robinson N., McComb S., Mulligan R., Dudani R., Krishnan L., et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat Immunol 2012, 13:954-962.
51. Thapa R.J., Nogusa S., Chen P., Maki J.L., Lerro A., et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc Natl Acad Sci U S A 2013, 110:E3109-E3118.
52. Moujalled D.M., Cook W.D., Okamoto T., Murphy J., Lawlor K.E., et al. TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis 2013, 4:e465.
53. Vanlangenakker N., Bertrand M.J., Bogaert P., Vandenabeele P., Vanden Berghe T. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis 2011, 2:e230.
54. Roychowdhury S., McMullen M.R., Pisano S.G., Liu X., Nagy L.E. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013, 57:1773-1783.
55. Rebsamen M., Heinz L.X., Meylan E., Michallet M.C., Schroder K., et al. DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep 2009, 10:916-922.
56. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:302-313.
57. Upton J.W., Kaiser W.J., Mocarski E.S. DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe 2012, 11:290-297.
58. He S., Liang Y., Shao F., Wang X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A 2011, 108:20054-20059.
59. Kaiser W.J., Sridharan H., Huang C., Mandal P., Upton J.W., et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3 and MLKL. J Biol Chem 2013, 288:31268-31279.
60. Cusson-Hermance N., Khurana S., Lee T.H., Fitzgerald K.A., Kelliher M.A. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-{kappa}B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 2005, 280:36560-36566.
61. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276.
62. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., et al. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
63. Kaiser W.J., Upton J.W., Long A.B., Livingston-Rosanoff D., Daley-Bauer L.P., et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 2011, 471:368-372.
64. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279:1954-1958.
65. Zhang J., Cado D., Chen A., Kabra N.H., Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998, 392:296-300.
66. Dillon C.P., Oberst A., Weinlich R., Janke L.J., Kang T.B., et al. Survival function of the FADD-CASPASE-8-cFLIP(L) complex. Cell Rep 2012, 1:401-407.
67. Zhang H., Zhou X., McQuade T., Li J., Chan F.K., et al. Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 2011, 471:373-376.
68. Hildebrand J.M., Sun L., Silke J. An appointment with death: 2013 Cold Spring Harbor Asia meeting 'Mechanisms and Functions of Non-Apoptotic Cell Death'. Cell Death Differ 2013, 20:1593-1594.
69. Ch'en I.L., Tsau J.S., Molkentin J.D., Komatsu M., Hedrick S.M. Mechanisms of necroptosis in T cells. J Exp Med 2011, 208:633-641.
70. Bell B.D., Leverrier S., Weist B.M., Newton R.H., Arechiga A.F., et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A 2008, 105:16677-16682.
71. Ch'en I.L., Beisner D.R., Degterev A., Lynch C., Yuan J., et al. Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A 2008, 105:17463-17468.
72. Lu J.V., Weist B.M., van Raam B.J., Marro B.S., Nguyen L.V., et al. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity. Proc Natl Acad Sci U S A 2011, 108:15312-15317.
73. Osborn S.L., Diehl G., Han S.J., Xue L., Kurd N., et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A 2010, 107:13034-13039.
74. Kang T.B., Oh G.S., Scandella E., Bolinger B., Ludewig B., et al. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J. Immunol 2008, 181:2522-2532.
75. Lin Y., Devin A., Rodriguez Y., Liu Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 1999, 13:2514-2526.
76. Feng S., Yang Y., Mei Y., Ma L., Zhu D.E., et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007, 19:2056-2067.
77. Mocarski E.S., Upton J.W., Kaiser W.J. Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol 2012, 12:79-88.
78. Pearson J.S., Giogha C., Ong S.Y., Kennedy C.L., Kelly M., et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 2013, 501:247-251.
79. Li S., Zhang L., Yao Q., Li L., Dong N., et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013, 501:242-246.
80. Zhao J., Jitkaew S., Cai Z., Choksi S., Li Q., et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A 2012, 109:5322-5327.
81. Wu J., Huang Z., Ren J., Zhang Z., He P., et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res 2013, 23:994-1006.
82. Murphy J.M., Czabotar P.E., Hildebrand J.M., Lucet I.S., Zhang J.G., et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity 2013, 39:443-453.
83. Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S. The protein kinase complement of the human genome. Science 2002, 298:1912-1934.
84. Eyers P.A., Murphy J.M. Dawn of the dead: protein pseudokinases signal new adventures in cell biology. Biochem Soc Trans 2013, 41:969-974.
85. Xie T., Peng W., Yan C., Wu J., Gong X., et al. Structural insights into RIP3-mediated necroptotic signaling. Cell Rep 2013, 5:70-78.
86. Wang Z., Jiang H., Chen S., Du F., Wang X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 2012, 148:228-243.
87. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 1992, 267:5317-5323.
88. Lin Y., Choksi S., Shen H.M., Yang Q.F., Hur G.M., et al. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004, 279:10822-10828.
89. Khwaja A., Tatton L. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem 1999, 274:36817-36823.
90. Park S.Y., Shim J.H., Cho Y.S. Distinctive roles of receptor-interacting protein kinases 1 and 3 in caspase-independent cell death of L929. Cell Biochem Funct 2013, [Epub ahead of print]. 10.1002/cbf.2972.
91. Shindo R., Kakehashi H., Okumura K., Kumagai Y., Nakano H. Critical contribution of oxidative stress to TNFalpha-induced necroptosis downstream of RIPK1 activation. Biochem Biophys Res Commun 2013, 436:212-216.
92. Roca F.J., Ramakrishnan L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 2013, 153:521-534.
93. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci U S A 1995, 92:8115-8119.
94. Goossens V., Grooten J., Fiers W. The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J Biol Chem 1996, 271:192-196.
95. Kikuchi M., Kuroki S., Kayama M., Sakaguchi S., Lee K.K., et al. Protease activity of procaspase-8 is essential for cell survival by inhibiting both apoptotic and nonapoptotic cell death dependent on receptor-interacting protein kinase 1 (RIP1) and RIP3. J Biol Chem 2012, 287:41165-41173.
96. Fortes G.B., Alves L.S., de Oliveira R., Dutra F.F., Rodrigues D., et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. Blood 2012, 119:2368-2375.
97. Sakon S., Xue X., Takekawa M., Sasazuki T., Okazaki T., et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. Embo J 2003, 22:3898-3909.
98. Davis C.W., Hawkins B.J., Ramasamy S., Irrinki K.M., Cameron B.A., et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic Biol Med 2010, 48:306-317.
99. Wu Y.T., Tan H.L., Huang Q., Sun X.J., Zhu X., et al. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 2011, 18:26-37.
100. Devin A., Lin Y., Liu Z.G. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep 2003, 4:623-627.
101. Lee T.H., Huang Q., Oikemus S., Shank J., Ventura J.J., et al. The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 2003, 23:8377-8385.
102. Wong W.W., Gentle I.E., Nachbur U., Anderton H., Vaux D.L., et al. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ 2010, 17:482-487.
103. McNamara C.R., Ahuja R., Osafo-Addo A.D., Barrows D., Kettenbach A., et al. Akt regulates TNFalpha synthesis downstream of RIP1 kinase activation during necroptosis. PLoS ONE 2013, 8:e56576.
104. Christofferson D.E., Li Y., Hitomi J., Zhou W., Upperman C., et al. A novel role for RIP1 kinase in mediating TNFalpha production. Cell Death Dis 2012, 3:e320.
105. Sun X., Lee J., Navas T., Baldwin D.T., Stewart T.A., et al. RIP3, a novel apoptosis-inducing kinase. J Biol Chem 1999, 274:16871-16875.
106. Yu P.W., Huang B.C., Shen M., Quast J., Chan E., et al. Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol 1999, 9:539-542.
107. Vince J.E., Wong W.W., Gentle I., Lawlor K.E., Allam R., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
108. Dondelinger Y., Aguileta M.A., Goossens V., Dubuisson C., Grootjans S., et al. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition. Cell Death Differ 2013, 20:1381-1392.
109. Menu P., Vince J.E. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011, 166:1-15.
110. Kang T.B., Yang S.H., Toth B., Kovalenko A., Wallach D. Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3. Inflamm Immun 2013, 38:27-40.
111. Lawlor K.E., Vince J.E. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria?. Biochim Biophys Acta 2013, [Epub ahead of print]. 10.1016/j.bbagen.2013.08.014.
112. Linkermann A., Brasen J.H., Darding M., Jin M.K., Sanz A.B., et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A 2013, 110:12024-12029.
113. Linkermann A., Brasen J.H., Himmerkus N., Liu S., Huber T.B., et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 2012, 81:751-761.
114. Smith C.C., Davidson S.M., Lim S.Y., Simpkin J.C., Hothersall J.S., et al. Necrostatin: a potentially novel cardioprotective agent?. Cardiovasc Drugs Ther 2007, 21:227-233.
115. Oerlemans M.I., Liu J., Arslan F., den Ouden K., van Middelaar B.J., et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol 2012, 107:270.
116. Northington F.J., Chavez-Valdez R., Graham E.M., Razdan S., Gauda E.B., et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011, 31:178-189.
117. Krajewska M., You Z., Rong J., Kress C., Huang X., et al. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS ONE 2011, 6:e24341.
118. Feng Y., Fratkin J.D., LeBlanc M.H. Inhibiting caspase-8 after injury reduces hypoxic-ischemic brain injury in the newborn rat. Eur J Pharmacol 2003, 481:169-173.
119. You Z., Savitz S.I., Yang J., Degterev A., Yuan J., et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008, 28:1564-1573.
120. Zhu S., Zhang Y., Bai G., Li H. Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease. Cell Death Dis 2011, 2:e115.
121. Murakami Y., Matsumoto H., Roh M., Suzuki J., Hisatomi T., et al. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A 2012, 109:14598-14603.
122. Murakami Y., Matsumoto H., Roh M., Giani A., Kataoka K., et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ 2013, [Epub ahead of print]. 10.1038/cdd.2013.109.
123. Trichonas G., Murakami Y., Thanos A., Morizane Y., Kayama M., et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci U S A 2010, 107:21695-21700.
124. Linkermann A., Brasen J.H., De Zen F., Weinlich R., Schwendener R.A., et al. Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock. Mol Med 2012, 18:577-586.
125. Lin J., Li H., Yang M., Ren J., Huang Z., et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 2013, 3:200-210.
126. Roychowdhury S., Chiang D.J., Mandal P., McMullen M.R., Liu X., et al. Inhibition of apoptosis protects mice from ethanol-mediated acceleration of early markers of CCl(4)-induced fibrosis but not steatosis or inflammation. Alcohol Clin Exp Res 2012, 36:1139-1147.
127. McNeal S.I., LeGolvan M.P., Chung C.S., Ayala A. The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis. Shock 2011, 35:499-505.
128. Duprez L., Takahashi N., Van Hauwermeiren F., Vandendriessche B., Goossens V., et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 2011, 35:908-918.
129. Liedtke C., Bangen J.M., Freimuth J., Beraza N., Lambertz D., et al. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 2011, 141:2176-2187.
130. Kaufmann T., Jost P.J., Pellegrini M., Puthalakath H., Gugasyan R., et al. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 2009, 30:56-66.
131. Ebermann L., Ruzsics Z., Guzman C.A., van Rooijen N., Casalegno-Garduno R., et al. Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. PLoS Pathog 2012, 8:e1003062.
132. Gunther C., Martini E., Wittkopf N., Amann K., Weigmann B., et al. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature 2011, 477:335-339.
133. Vucur M., Reisinger F., Gautheron J., Janssen J., Roderburg C., et al. RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep 2013, 4:776-790.
134. Wittkopf N., Gunther C., Martini E., He G., Amann K., et al. Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8. Gastroenterology 2013, [Epub ahead of print]. 10.1053/j.gastro.2013.08.059.
135. Welz P.S., Wullaert A., Vlantis K., Kondylis V., Fernandez-Majada V., et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 2011, 477:330-334.
136. Bonnet M.C., Preukschat D., Welz P.S., van Loo G., Ermolaeva M.A., et al. The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 2011, 35:572-582.
137. Lukens J.R., Vogel P., Johnson G.R., Kelliher M.A., Iwakura Y., et al. RIP1-driven autoinflammation targets IL-1alpha independently of inflammasomes and RIP3. Nature 2013, 498:224-227.
138. Murphy J.M., Lucet I.S., Hildebrand J.M., Tanzer M.C., Young S.N., Sharma P., Lessene G., Alexander W.S., Babon J.J., Silke J., Czabotar P.E. Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL. Biochem J 2013, 10.1042/BJ20131270.